Research Articles | Page 13 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM) Feb 2021 Journal of clinical oncology: official journal of the American Society Clinical Oncology myelodysplastic syndromes (MDS)
Detectable mutations precede late myeloid neoplasia in aplastic anemia Feb 2021 Haematologica aplastic anemia
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantat Feb 2021 Journal for immunotherapy of cancer myelodysplastic syndromes (MDS)
Luspatercept in the treatment of lower-risk myelodysplastic syndromes Jan 2021 Future Oncology (London, England) myelodysplastic syndromes (MDS)
Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options Jan 2021 Cancer Management and Research myelodysplastic syndromes (MDS)
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Jan 2021 Leukemia myelodysplastic syndromes (MDS)
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria Jan 2021 Leukemia paroxysmal nocturnal hemoglobinuria (PNH)
How I Treat Paroxysmal nocturnal hemoglobinuria Jan 2021 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes Jan 2021 American Journal of Hematology myelodysplastic syndromes (MDS)
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes Jan 2021 Journal of clinical oncology: official journal of the American Society Clinical Oncology myelodysplastic syndromes (MDS)
Share with addtoany.com.